Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-11

Clinical Trial Update: Tranexamic Acid in HIp Fracture Surgery (THIF Study) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tranexamic acid in hip fracture surgery has completed. The THIF study looked at tranexamic acid to reduce bleeding during hip fracture …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Hip Fracture | Phase 3 | Status: COMPLETED